Clinical and Pathological Features of Vasculitic Neuropathy: A Single‐Center Study in China
European Journal of Neurology · 2026-03 · 33 (3)
DOI: 10.1111/ene.70540 ↗At a glance
Journal article in European Journal of Neurology, published online on 2026-03-14. Written by Xiaoyu Zhou and 9 co-authors. Institution: Department of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Labor…. Major MEDLINE topics: Vasculitis, Peripheral Nervous System Diseases. 47 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Key R&D Program of Shandong Province, China, National Natural Science Foundation of China.
Abstract (original language)
Background
Vasculitic neuropathy (VN) is a disease in which vessel inflammation happens and injures peripheral nerves. Despite increasing awareness, features of VN in mainland China are still understudied.
Objective
To characterize the clinical, pathological features and outcomes of VN in mainland China, and evaluate clinicopathological correlations: Methods We retrospectively reviewed records of VN patients diagnosed pathologically between June 1999 and December 2024, including demographic data, clinical manifestations, biopsy features, and outcomes.
Results
112 patients were totally included. All presented with axonal sensorimotor neuropathy, most commonly involving the tibial (90.63%) and peroneal (87.50%) nerves. Systemic VN (SVN) showed more frequent transmural inflammatory cell infiltration (ICI) than non‐systemic VN (NSVN) ( p = 0.046). Eosinophilic granulomatosis with polyangiitis (EGPA) was more common in VN without ICI than VN with ICI ( p = 0.008). In SVN, the ICI‐positive exhibited more severe distal upper limb weakness ( p = 0.042) and higher thrombosis rates ( p = 0.001) than ICI‐negative. Of the 63 patients followed, 62 received glucocorticoids with or without immunosuppressants. Thirteen died from multi‐organ complications (12 SVN and 1 NSVN), while others achieved remission. The 5‐year all‐survival rate was 80.23% (95% CI 66.83%– 88.66%).
Conclusions
This first large cohort of VN in mainland China delineates its clinical–pathological features. EGPA showed a lower diagnostic yield on biopsy, suggesting diverse mechanisms of vascular injury. Nerve biopsy remains the diagnostic gold standard. The overall prognosis of VN is relatively favorable, emphasizing the need for early recognition and treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Neurology, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Jinan, Shandong, Ch…
ORCID profiles: Didi Shan, Bin Wu, Fuchen Liu, Yuying Zhao, Chuanzhu Yan, Jingwen Xu
Funding
- Key R&D Program of Shandong Province, China
- National Natural Science Foundation of China
Cite
APA
Zhou, X., Shan, D., Wu, B., Liu, F., Zhang, D., Lin, P., Li, W., Zhao, Y., Yan, C., & Xu, J. (2026). Clinical and Pathological Features of Vasculitic Neuropathy: A Single‐Center Study in China. European Journal of Neurology, 33(3). https://doi.org/10.1111/ene.70540
Vancouver
Zhou X, Shan D, Wu B, Liu F, Zhang D, Lin P, et al. Clinical and Pathological Features of Vasculitic Neuropathy: A Single‐Center Study in China. European Journal of Neurology. 2026;33(3). doi:10.1111/ene.70540
BibTeX
@article{Zhou2026,
author = {Zhou, Xiaoyu and Shan, Didi and Wu, Bin and Liu, Fuchen and Zhang, Dong and Lin, Pengfei and Li, Wei and Zhao, Yuying and Yan, Chuanzhu and Xu, Jingwen},
title = {Clinical and Pathological Features of Vasculitic Neuropathy: A Single‐Center Study in China},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {3},
doi = {10.1111/ene.70540}
}
EUVIMED